Report Detail
Global HER-2 Targeted Drugs for Breast Cancer
- RnM3475183 |
- 30 May, 2019 |
- Global |
- 119 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
According to this study, over the next five years the HER-2 Targeted Drugs for Breast Cancer market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in HER-2 Targeted Drugs for Breast Cancer business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of HER-2 Targeted Drugs for Breast Cancer market by product type, application, key companies and key regions.
This study considers the HER-2 Targeted Drugs for Breast Cancer value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Trastuzumab
Pertuzumab
Neratinib
Trastuzumab Emtansine
Pyrotinib
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Clinic
Drug Center
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Chugai Pharmaceutical
GlaxoSmithKline
Novartis
Pfizer
CANbridge
Puma Biotechnology
Hengrui Medicine
Beacon Pharmaceuticals Limited
Hetero Drugs
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global HER-2 Targeted Drugs for Breast Cancer market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of HER-2 Targeted Drugs for Breast Cancer market by identifying its various subsegments.
Focuses on the key global HER-2 Targeted Drugs for Breast Cancer players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the HER-2 Targeted Drugs for Breast Cancer with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of HER-2 Targeted Drugs for Breast Cancer submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global HER-2 Targeted Drugs for Breast Cancer Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size 2014-2024
- 2.1.2 HER-2 Targeted Drugs for Breast Cancer Market Size CAGR by Region
- 2.2 HER-2 Targeted Drugs for Breast Cancer Segment by Type
- 2.2.1 Trastuzumab
- 2.2.2 Pertuzumab
- 2.2.3 Lapatinib
- 2.2.4 Neratinib
- 2.2.5 Trastuzumab Emtansine
- 2.2.6 Pyrotinib
- 2.2.7 Other
- 2.3 HER-2 Targeted Drugs for Breast Cancer Market Size by Type
- 2.3.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size Market Share by Type (2014-2019)
- 2.3.2 Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Type (2014-2019)
- 2.4 HER-2 Targeted Drugs for Breast Cancer Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Drug Center
- 2.4.4 Other
- 2.5 HER-2 Targeted Drugs for Breast Cancer Market Size by Application
- 2.5.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size Market Share by Application (2014-2019)
- 2.5.2 Global HER-2 Targeted Drugs for Breast Cancer Market Size Growth Rate by Application (2014-2019)
3 Global HER-2 Targeted Drugs for Breast Cancer by Players
- 3.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size Market Share by Players
- 3.1.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size by Players (2017-2019)
- 3.1.2 Global HER-2 Targeted Drugs for Breast Cancer Market Size Market Share by Players (2017-2019)
- 3.2 Global HER-2 Targeted Drugs for Breast Cancer Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 HER-2 Targeted Drugs for Breast Cancer by Regions
- 4.1 HER-2 Targeted Drugs for Breast Cancer Market Size by Regions
- 4.2 Americas HER-2 Targeted Drugs for Breast Cancer Market Size Growth
- 4.3 APAC HER-2 Targeted Drugs for Breast Cancer Market Size Growth
- 4.4 Europe HER-2 Targeted Drugs for Breast Cancer Market Size Growth
- 4.5 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size Growth
5 Americas
- 5.1 Americas HER-2 Targeted Drugs for Breast Cancer Market Size by Countries
- 5.2 Americas HER-2 Targeted Drugs for Breast Cancer Market Size by Type
- 5.3 Americas HER-2 Targeted Drugs for Breast Cancer Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC HER-2 Targeted Drugs for Breast Cancer Market Size by Countries
- 6.2 APAC HER-2 Targeted Drugs for Breast Cancer Market Size by Type
- 6.3 APAC HER-2 Targeted Drugs for Breast Cancer Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe HER-2 Targeted Drugs for Breast Cancer by Countries
- 7.2 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Type
- 7.3 Europe HER-2 Targeted Drugs for Breast Cancer Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer by Countries
- 8.2 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Type
- 8.3 Middle East & Africa HER-2 Targeted Drugs for Breast Cancer Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global HER-2 Targeted Drugs for Breast Cancer Market Forecast
- 10.1 Global HER-2 Targeted Drugs for Breast Cancer Market Size Forecast (2019-2024)
- 10.2 Global HER-2 Targeted Drugs for Breast Cancer Forecast by Regions
- 10.2.1 Global HER-2 Targeted Drugs for Breast Cancer Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global HER-2 Targeted Drugs for Breast Cancer Forecast by Type
- 10.8 Global HER-2 Targeted Drugs for Breast Cancer Forecast by Application
11 Key Players Analysis
- 11.1 Roche
- 11.1.1 Company Details
- 11.1.2 HER-2 Targeted Drugs for Breast Cancer Product Offered
- 11.1.3 Roche HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Roche News
- 11.2 Chugai Pharmaceutical
- 11.2.1 Company Details
- 11.2.2 HER-2 Targeted Drugs for Breast Cancer Product Offered
- 11.2.3 Chugai Pharmaceutical HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Chugai Pharmaceutical News
- 11.3 GlaxoSmithKline
- 11.3.1 Company Details
- 11.3.2 HER-2 Targeted Drugs for Breast Cancer Product Offered
- 11.3.3 GlaxoSmithKline HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 GlaxoSmithKline News
- 11.4 Novartis
- 11.4.1 Company Details
- 11.4.2 HER-2 Targeted Drugs for Breast Cancer Product Offered
- 11.4.3 Novartis HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Novartis News
- 11.5 Pfizer
- 11.5.1 Company Details
- 11.5.2 HER-2 Targeted Drugs for Breast Cancer Product Offered
- 11.5.3 Pfizer HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Pfizer News
- 11.6 CANbridge
- 11.6.1 Company Details
- 11.6.2 HER-2 Targeted Drugs for Breast Cancer Product Offered
- 11.6.3 CANbridge HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 CANbridge News
- 11.7 Puma Biotechnology
- 11.7.1 Company Details
- 11.7.2 HER-2 Targeted Drugs for Breast Cancer Product Offered
- 11.7.3 Puma Biotechnology HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Puma Biotechnology News
- 11.8 Hengrui Medicine
- 11.8.1 Company Details
- 11.8.2 HER-2 Targeted Drugs for Breast Cancer Product Offered
- 11.8.3 Hengrui Medicine HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Hengrui Medicine News
- 11.9 Beacon Pharmaceuticals Limited
- 11.9.1 Company Details
- 11.9.2 HER-2 Targeted Drugs for Breast Cancer Product Offered
- 11.9.3 Beacon Pharmaceuticals Limited HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Beacon Pharmaceuticals Limited News
- 11.10 Hetero Drugs
- 11.10.1 Company Details
- 11.10.2 HER-2 Targeted Drugs for Breast Cancer Product Offered
- 11.10.3 Hetero Drugs HER-2 Targeted Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Hetero Drugs News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on HER-2 Targeted Drugs for Breast Cancer . Industry analysis & Market Report on HER-2 Targeted Drugs for Breast Cancer is a syndicated market report, published as Global HER-2 Targeted Drugs for Breast Cancer . It is complete Research Study and Industry Analysis of HER-2 Targeted Drugs for Breast Cancer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
